Skip to main content

Published locations for FDA begins priority review of cemiplimab for advanced cutaneous squamous cell carcinoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA begins priority review of cemiplimab for advanced cutaneous squamous cell carcinoma

User login

  • Reset your password
  • /content/fda-begins-priority-review-cemiplimab-advanced-cutaneous-squamous-cell-carcinoma
  • /edermatologynews/article/164666/nonmelanoma-skin-cancer/fda-begins-priority-review-cemiplimab
  • /oncologypractice/article/164666/nonmelanoma-skin-cancer/fda-begins-priority-review-cemiplimab
  • /hematology-oncology/article/164666/nonmelanoma-skin-cancer/fda-begins-priority-review-cemiplimab
  • /dermatology/article/164666/nonmelanoma-skin-cancer/fda-begins-priority-review-cemiplimab-advanced